Newsbenzinga
B. Riley Securities Maintains Buy on OptimizeRx, Raises Price Target to $11
· Published
Article summary
Please check the source for details.
An excerpt from the original article.Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…